Safaa Al-Thamiree Mezban
Research Subjects
Safaa Al-Thamiree Mezban has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Ammar Ihsan Awadh
College of Pharmacy, Al-Kunooze University
1 shared publication - Hanan Ramadhan
Department of Clinical Laboratory Science, College of Pharmacy, Basrah University
1 shared publication - Omar Farooq Abdul-Rasheed
Department of Biochemistry, College of Medicine, Al-Nahrain University
1 shared publication - Safaa Abdulabass Alhamedi
Department of Surgery, College of Medicine, Basrah University
1 shared publication - Simon William Fox
Department of Histopathology, St. George's Hospital Medical School, London, UK
1 shared publication
Latest Publications
- 2 November 2025
- Published by Marmara University in Journal of Research in Pharmacy
- Vol. 29 (6) , 2230-2238
The investigation of new mutations in telomerase reverse transcriptase promoter region in association with bladder cancer
Telomerase reverse transcriptase (TERT) is frequently reactivated in Urothelial Bladder Cancer (UBC) due to changes in its promoter region, rendering it a vital target for cancer-specific genetic modifications. The present work was aimed to investigate the TERT promoter region to explore the mutations that may affect the incidence and the pathogenesis of Urothelial Bladder Cancer in a study included 59 patients subjected to either transurethral bladder resection or radical cystectomy from which serum and tissue samples were obtained and the DNA extraction was performed with the use of purification Promega kit and the amplified DNA samples were sequenced by Sanger sequencing using an automated DNA sequencer to determine TERT gene promoter mutations. The results of the study showed that 47 patients out of 59 showed a mutation at the position -129 (1295233), 44 of them with c.232_233insA and 3 patients with a C233A mutation. Sixteen patients of the 59 patients subjected to the genetic analysis showed a mutation at the position -109 (1295213) in the TERT promoter region, the later mutation showed to be associated significantly with the grade of the reaction wheras the former mutation didn’t show that. On the other hand the two novel mutation showed a non-significant association with the levels of hTERT, age, gender, muscle invasiveness, recurrence and smoking and it was concluded from that the mutation in the TERT promoter region my have an effect on the TERT expression that participate in the bladder cancer pathogenisis which need further studies.
- 2 November 2025
- Published by Marmara University in Journal of Research in Pharmacy
- Vol. 29 (6) , 2230-2238
The investigation of new mutations in telomerase reverse transcriptase promoter region in association with bladder cancer
Telomerase reverse transcriptase (TERT) is frequently reactivated in Urothelial Bladder Cancer (UBC) due to changes in its promoter region, rendering it a vital target for cancer-specific genetic modifications. The present work was aimed to investigate the TERT promoter region to explore the mutations that may affect the incidence and the pathogenesis of Urothelial Bladder Cancer in a study included 59 patients subjected to either transurethral bladder resection or radical cystectomy from which serum and tissue samples were obtained and the DNA extraction was performed with the use of purification Promega kit and the amplified DNA samples were sequenced by Sanger sequencing using an automated DNA sequencer to determine TERT gene promoter mutations. The results of the study showed that 47 patients out of 59 showed a mutation at the position -129 (1295233), 44 of them with c.232_233insA and 3 patients with a C233A mutation. Sixteen patients of the 59 patients subjected to the genetic analysis showed a mutation at the position -109 (1295213) in the TERT promoter region, the later mutation showed to be associated significantly with the grade of the reaction wheras the former mutation didn’t show that. On the other hand the two novel mutation showed a non-significant association with the levels of hTERT, age, gender, muscle invasiveness, recurrence and smoking and it was concluded from that the mutation in the TERT promoter region my have an effect on the TERT expression that participate in the bladder cancer pathogenisis which need further studies.
- Open Access
- 24 March 2023
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 740, 109583
Genistein and coumestrol reduce MCF-7 breast cancer cell viability and inhibit markers of preferential metastasis, bone matrix attachment and tumor-induced osteoclastogenesis
- 24 March 2023
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 740, 109583
Open AccessGenistein and coumestrol reduce MCF-7 breast cancer cell viability and inhibit markers of preferential metastasis, bone matrix attachment and tumor-induced osteoclastogenesis